Quality of life (QOL) evaluation of patients in a phase 3 study comparing NEPA with an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV)
机构：[1]Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China;其他部门华南肿瘤学国家重点实验室中山大学肿瘤防治中心[2]Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China;[3]Jiangsu Canc Hosp, Med Oncol, Nanjing, Jiangsu, Peoples R China;[4]Prince Songkla Univ, Div Med Oncol, Internal Med, Hat Yai, Thailand;[5]Helsinn Healthcare, Corp Clin Dev, Lugano, Switzerland;[6]Helsinn Healthcare, Stat & Data Management, Lugano, Switzerland;[7]Heidelberg Univ, Dept Med 5, Heidelberg, Germany;[8]Clinque Genolier, Canc Ctr, Breast Ctr, Genolier, Switzerland
出处：
ISSN：
基金：
Helsinn Healthcare
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2017]版：
大类|1 区医学
小类|1 区肿瘤学
最新[2023]版：
大类|1 区医学
小类|1 区肿瘤学
第一作者：
第一作者机构：[1]Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China;
推荐引用方式(GB/T 7714)：
Zhang L.,Lu S.,Feng J.,et al.Quality of life (QOL) evaluation of patients in a phase 3 study comparing NEPA with an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV)[J].ANNALS OF ONCOLOGY.2017,28:-.
APA：
Zhang, L.,Lu, S.,Feng, J.,Dechaphunkul, A.,Chessari, S....&Aapro, M..(2017).Quality of life (QOL) evaluation of patients in a phase 3 study comparing NEPA with an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV).ANNALS OF ONCOLOGY,28,
MLA：
Zhang, L.,et al."Quality of life (QOL) evaluation of patients in a phase 3 study comparing NEPA with an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV)".ANNALS OF ONCOLOGY 28.(2017):-
医学